Compounds > 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
Page last updated: 2024-09-03

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Chronic Illness

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with Chronic Illness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Larson, ME; Richards, TM1

Other Studies

1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Chronic Illness

ArticleYear
Quantification of a methadone metabolite (EDDP) in urine: assessment of compliance.
    Clinical medicine & research, 2009, Volume: 7, Issue:4

    Topics: Analgesics, Opioid; Chronic Disease; Creatinine; Female; Follow-Up Studies; Humans; Male; Methadone; Monitoring, Physiologic; Pain; Pyrrolidines; Retrospective Studies; Substance-Related Disorders; Wisconsin

2009